DE3787377D1 - Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel. - Google Patents

Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.

Info

Publication number
DE3787377D1
DE3787377D1 DE87906972T DE3787377T DE3787377D1 DE 3787377 D1 DE3787377 D1 DE 3787377D1 DE 87906972 T DE87906972 T DE 87906972T DE 3787377 T DE3787377 T DE 3787377T DE 3787377 D1 DE3787377 D1 DE 3787377D1
Authority
DE
Germany
Prior art keywords
agents
application
transdermal administration
systemic
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87906972T
Other languages
English (en)
Other versions
DE3787377T2 (de
Inventor
Gevork Minaskanian
James Peck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitby Research Inc
Original Assignee
Whitby Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitby Research Inc filed Critical Whitby Research Inc
Application granted granted Critical
Publication of DE3787377D1 publication Critical patent/DE3787377D1/de
Publication of DE3787377T2 publication Critical patent/DE3787377T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/46Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom rings with more than six members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06PDYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P1/00General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
    • D06P1/44General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders
    • D06P1/64General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders using compositions containing low-molecular-weight organic compounds without sulfate or sulfonate groups
    • D06P1/642Compounds containing nitrogen
    • D06P1/6426Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Textile Engineering (AREA)
  • Medicinal Preparation (AREA)
DE87906972T 1986-10-07 1987-10-07 Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel. Expired - Fee Related DE3787377T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/916,403 US4801586A (en) 1986-04-23 1986-10-07 Penetration enhancers for transdermal delivery of systemic agents
PCT/US1987/002581 WO1988002765A1 (en) 1986-10-07 1987-10-07 Penetration enhancers for transdermal delivery of systemic agents

Publications (2)

Publication Number Publication Date
DE3787377D1 true DE3787377D1 (de) 1993-10-14
DE3787377T2 DE3787377T2 (de) 1994-04-28

Family

ID=25437217

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87906972T Expired - Fee Related DE3787377T2 (de) 1986-10-07 1987-10-07 Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.

Country Status (8)

Country Link
US (1) US4801586A (de)
EP (1) EP0325613B1 (de)
JP (1) JPH0729939B2 (de)
KR (1) KR880701550A (de)
AU (1) AU606093B2 (de)
CA (1) CA1306692C (de)
DE (1) DE3787377T2 (de)
WO (1) WO1988002765A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1319613C (en) * 1986-10-07 1993-06-29 Gevork Minaskanian Penetration enhancers for transdermal delivery of systemic agents
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US4996199A (en) * 1988-04-08 1991-02-26 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5703104A (en) * 1995-07-07 1997-12-30 Durham Pharmaceuticals Llc Cyclic amides and derivatives thereof
US9855732B2 (en) 1999-01-25 2018-01-02 3M Innovative Properties Company Method of applying adhesive coated film
BR0007687A (pt) 1999-01-25 2002-01-29 3M Innovative Properties Co Processo de adesão de um filme revestido por adesivo a um substrato possuindo uma superfìcie, artigo para amolecer um filme e aderir o filme em uma superfìcie de um substrato, processo para economizar trabalho de aderência de um filme revestido de adesivo a um substrato possuindo uma superfìcie, e, kit para a aplicação de filmes a um substrato
US6147102A (en) * 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
MY139721A (en) 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
DE60204229T2 (de) * 2002-12-02 2006-02-02 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
MXPA06003316A (es) 2003-10-10 2006-06-08 Antares Pharma Ipl Ag Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
EP1933852B1 (de) 2005-09-27 2018-12-19 TissueTech, Inc. Amnion-zubereitungen und gereinigte zusammensetzungen und anwendungsverfahren
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
US20070248657A1 (en) * 2006-04-25 2007-10-25 Smith David J Multi-compartment transdermal pain control device
US20090220436A1 (en) * 2006-05-11 2009-09-03 Living Proof, Inc. In situ polymerization for skin treatment
US8778122B2 (en) 2006-06-29 2014-07-15 3M Innovative Properties Company Adhering graphic films on irregular substrates
EP1987815A1 (de) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen
EP3238696A1 (de) 2007-10-10 2017-11-01 Therametics, Llc Verfahren und zusammensetzungen zur behandlung von hauterkrankungen und -leiden
CN102223791A (zh) 2008-09-27 2011-10-19 塔阿克斯有限公司 用于神经病变治疗的局部用制剂
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
EP2717888B1 (de) 2011-06-10 2020-09-09 Tissuetech, Inc. Verfahren zur verarbeitung fötaler gewebesubstrate
CA2844115C (en) 2011-08-26 2021-11-23 Tissuetech, Inc. Methods of sterilizing fetal support tissues
US10525021B2 (en) 2014-11-18 2020-01-07 Rutgers, The State University Of New Jersey Mitochondrial uncouplers for treatment of metabolic diseases and cancer
JP7017523B2 (ja) 2016-05-18 2022-02-08 ラットガーズ、ザ ステート ユニバーシティ オブ ニュージャージー 代謝性疾患および癌の治療のための新規のミトコンドリア脱共役剤
CA3147431A1 (en) 2019-07-16 2021-01-21 Donaghys Limited Transdermal solvent system and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343426A (en) * 1971-05-07 1974-01-10 Dow Corning Tld Acylated lactams
US4562075A (en) * 1982-05-20 1985-12-31 Nelson Research & Development Co. Penetration enhancers for transdermal drug delivery of systemic agents
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4525199A (en) * 1981-05-04 1985-06-25 Nelson Research & Development Co. Method of improved pest control
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4415563A (en) * 1980-04-04 1983-11-15 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclononan-2-ones
US4424210A (en) * 1980-04-04 1984-01-03 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4423040A (en) * 1980-04-04 1983-12-27 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclohexan-2-ones
YU141080A (en) * 1980-05-24 1983-04-30 Sour Pliva Process for preparing n-chlorocarbonl-lactams
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
CA1298557C (en) * 1986-01-31 1992-04-07 Whitby Research Incorporated Compositions comprising 1-substituted azacyclo-alkanes
WO1987004594A1 (en) * 1986-01-31 1987-08-13 Nelson Research And Development Company Compositions comprising 1-substituted azacycloalkanes and their uses
US4755535A (en) * 1986-04-23 1988-07-05 Nelson Research & Development Co. Compositions comprising 1-substituted azacycloalkenes

Also Published As

Publication number Publication date
JPH02500028A (ja) 1990-01-11
CA1306692C (en) 1992-08-25
AU8104087A (en) 1988-05-06
KR880701550A (ko) 1988-11-03
US4801586A (en) 1989-01-31
EP0325613B1 (de) 1993-09-08
WO1988002765A1 (en) 1988-04-21
AU606093B2 (en) 1991-01-31
EP0325613A4 (de) 1989-06-13
DE3787377T2 (de) 1994-04-28
JPH0729939B2 (ja) 1995-04-05
EP0325613A1 (de) 1989-08-02

Similar Documents

Publication Publication Date Title
DE3787377D1 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
NO873298D0 (no) Oralt terapeutisk system med stystemisk virkning.
DE3685094D1 (de) Pharmazeutisches praeparat zur kontrollierten freisetzung von wirkstoffen.
NO883591D0 (no) Dermal administreringsform.
DK184087A (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
DK413987D0 (da) Farmaceutiske praeparater
DE3676601D1 (de) Mittel zur injektion von aktiviertem vitamin-d3.
NO874824D0 (no) Bruker-aktivert transdermalt terapeutisk system.
DK346287D0 (da) Transdermal indgivelsesanordning
DE3585722D1 (de) Geraet zur iontophoretischen verabreichung von medikamenten.
DK652787A (da) Farmaceutiske praeparater
MC1878A1 (fr) Compositions pharmaceutiques
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
MX5577A (es) Formulacion farmaceutica
DK400487D0 (da) Transdermale praeparater
DE3674017D1 (de) Oxalursaeure-derivate und pharmazeutisches mittel.
DK142487A (da) Farmaceutiske midler
DK447887A (da) Frysetoerrede farmaceutiske praeparater
DE3782594D1 (de) Arzneimittel zur transdermalen verabreichung von nicorandil.
DE3769843D1 (de) Mittel zur verhinderung von krustungsbildung.
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
DE3750264D1 (de) Durchdringungserhöhende mittel für transdermale verabreichung systemischer mittel.
FI875325A (fi) Bestraolningsanordning foer synbart ljus vid medicinal anvaendning.
DK100087A (da) Transdermale 3-phenoxypyridin-praeparater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee